Canadian Leadership Council on Drug Plan Partnerships
May 7, 2024 | Vantage Venues, Toronto
May 7, 2024
8:00 – 9:00 AM:
Breakfast (St. Andrew’s Lounge)
9:00 – 9:05 AM:
Introduction (St. Andrew’s Hall)
Facilitators:
Francesca Allman, director of sales, Benefits Canada
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
9:05 – 9:20 AM:
The value of medications and the private payer market
Speaker:
Ugur Gunaydin, vice-president and general manager, Amgen Canada Inc.
9:20 – 9:40 AM:
Private drug claims: Trends and cost drivers
Speaker:
Joe Farago, executive director, private payers and investment, Innovative Medicines Canada
9:40 – 10:10 AM:
Moderated discussion
Facilitator:
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
10:10 – 10:45 AM:
Networking break (St. Andrew’s Lounge)
10:45 – 11:10 AM:
Managing risk
Speaker:
Paul Henricks, associate director, data innovation and insights, PDCI Market Access
11:10 – 11:40 AM:
Moderated discussion
Facilitator:
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
11:40 AM – 12:20 PM:
Lunch (St. Andrew’s Lounge)
12:20 – 12:50 PM:
The role of private payers in chronic disease management
Speakers:
Amine Bouchaib, director, patient access, obesity and rare disease, Novo Nordisk Canada
Martine Carbonneau, director, field patient access, Novo Nordisk Canada
12:50 – 1:20 PM:
Moderated discussion
Facilitator:
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
1:20 – 2:05 PM:
Panel: Best practices for drug plan management
This panel discussion will include highlights from Benefits Canada’s Plan Sponsor’s Guide to Drug Formularies and Prior Authorization.
Panellists:
Denise Balch, project manager, Simplify Prior Authorization Initiative; principal consultant, Crosslinks; and president, Connex Health
Philippe Lagacé, principal, health and benefits, Mercer Marsh Benefits
Nina Lathia, health economics consultant and founder and chief executive officer, Healthcare Decision Making
Kim Steele, director, government and community relations, Cystic Fibrosis Canada
Moderator:
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
2:05 – 2:35 PM:
Moderated discussion
Facilitator:
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
2:35 – 3:35 PM:
Discussion: Recommendations from council members
Facilitator:
Suzanne Lepage, private health plan strategist, Suzanne Lepage Consulting Inc.
3:35 – 3:45 PM:
Closing remarks
Facilitator:
Francesca Allman, director of sales, Benefits Canada